Literature DB >> 3795022

Oral absorption of 21-corticosteroid esters: a function of aqueous stability and intestinal enzyme activity and distribution.

D Fleisher, K C Johnson, B H Stewart, G L Amidon.   

Abstract

The intestinal absorption of hydrocortisone and prednisolone are compared with three water-soluble derivatives (succinate, phosphate, and lysinate) in experiments at two levels of biological system complexity. Rates of absorption are compared by measuring permeabilities from rat intestinal perfusions of drugs and derivatives in solution. Extents of absorption are compared over a 10-fold dose range of parent steroid and with the steroid derivatives by measuring plasma levels from solid oral dosage in dogs. While the parent steroids are well absorbed over the entire length of the intestinal tract, variability in plasma levels is observed at higher doses. Limited solubility and resultant dissolution rate variability are likely to be playing a role in the early erratic blood level profiles found at higher doses. While the soluble prodrugs have a dissolution rate advantage which results in a greater concentration gradient, their absorption is limited by their aqueous luminal stability, their polarity and resultant passive membrane permeability, and the distribution and activity of enzyme reconversion sites in the intestinal tract. The unstable lysinate ester, targeted for aminopeptidase, has an absorption profile and permeability similar to that of the parent steroid. The absorption of the moderately stable succinate ester is limited by its polarity and the activity of intestinal esterases. The stable phosphate derivative is well absorbed in the upper intestine, where high levels of alkaline phosphatase exist, while the prodrug polarity and drop-off of enzyme activity limit its absorption from the lower gastrointestinal (GI) tract.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3795022     DOI: 10.1002/jps.2600751004

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  5 in total

Review 1.  Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications.

Authors:  D Fleisher; C Li; Y Zhou; L H Pao; A Karim
Journal:  Clin Pharmacokinet       Date:  1999-03       Impact factor: 6.447

2.  Development of anti-influenza virus drugs I: improvement of oral absorption and in vivo anti-influenza activity of Stachyflin and its derivatives.

Authors:  S Yagi; J Ono; J Yoshimoto; K Sugita; N Hattori; T Fujioka; T Fujiwara; H Sugimoto; K Hirano; N Hashimoto
Journal:  Pharm Res       Date:  1999-07       Impact factor: 4.200

3.  Evaluation of a targeted prodrug strategy of enhance oral absorption of poorly water-soluble compounds.

Authors:  O H Chan; H L Schmid; L A Stilgenbauer; W Howson; D C Horwell; B H Stewart
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

4.  Absorption rate limit considerations for oral phosphate prodrugs.

Authors:  Tycho Heimbach; Doo-Man Oh; Lilian Y Li; Markus Forsberg; Jouko Savolainen; Jukka Leppänen; Yasushi Matsunaga; Gordon Flynn; David Fleisher
Journal:  Pharm Res       Date:  2003-06       Impact factor: 4.200

5.  Evaluation of food effects on the pharmacokinetics of Pelargonium sidoides and Coptis with each bioactive compound berberine and epicatechin after a single oral dose of an expectorant and antitussive agent UI026 in healthy subjects.

Authors:  Yewon Park; WonTae Jung; Eunsol Yang; Kyu-Yeol Nam; Woo-Ri Bong; Jaehee Kim; Kyu Yeon Kim; SeungHwan Lee; Joo-Youn Cho; Jang-Hee Hong; JaeWoo Kim
Journal:  Transl Clin Pharmacol       Date:  2022-03-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.